<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04502940</url>
  </required_header>
  <id_info>
    <org_study_id>Pancreatitis 01.06.2020</org_study_id>
    <nct_id>NCT04502940</nct_id>
  </id_info>
  <brief_title>Is Lymphocyte Subtype Important for Acute Pancreatitis Severity?</brief_title>
  <official_title>Can we Measure Pancreatitis Severity With Flow Cytometry?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pancreatitis is a common complication especially in patients with gallbladder stones, most&#xD;
      patients with biliary pancreatitis may recover spontaneously without sequelae, but in 10-20%&#xD;
      of patients, the disease is severe and mortality rates of up to 30% are detected in these&#xD;
      patients. In the evaluation of acute biliary pancreatitis, many scoring systems have been&#xD;
      established (Atlanta, Ranson, APACHE, BISAP etc.) from past to present to determine morbidity&#xD;
      and mortality of the disease.&#xD;
&#xD;
      In this study, the investigators aimed to evaluate the correlation between morbidity and&#xD;
      mortality of acute biliary pancreatitis and lymphocyte subtypes with Flow-cytometry.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pancreatitis is a common complication especially in patients with gallbladder stones, most&#xD;
      patients with biliary pancreatitis may recover spontaneously without sequelae, but in 10-20%&#xD;
      of patients, the disease is severe and mortality rates of up to 30% are detected in these&#xD;
      patients. In patients with severe pancreatitis, aggressive fluid replacement, organ damage&#xD;
      follow-up, appropriate antibiotherapy, and endoscopic sphincterotomy and radiological&#xD;
      interventions may be of great benefit. In the evaluation of acute biliary pancreatitis, many&#xD;
      scoring systems have been established (Atlanta, Ranson, APACHE, BISAP etc.) from past to&#xD;
      present to determine morbidity and mortality of the disease. There are limited number of&#xD;
      studies in the literature about the immune parameters in the evaluation of acute&#xD;
      pancreatitis. In a studies, serum inflammatory markers such as IL-1, IL-6 and CD4, CD8 T&#xD;
      lymphocyte and Treg population were evaluated.Treg cells are reported to be an independent&#xD;
      prognostic factor in determining the severity of acute pancreatitis. In patients diagnosed&#xD;
      with acute biliary pancreatitis, determination of the course of the disease at the time of&#xD;
      diagnosis is extremely important for treatment and survival.&#xD;
&#xD;
      In this study, the investigators aimed to evaluate the correlation between morbidity and&#xD;
      mortality of acute biliary pancreatitis with lymphocyte subtypes via Flow-cytometry.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Actual">April 29, 2021</completion_date>
  <primary_completion_date type="Actual">April 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lymphocyte subtypes 1</measure>
    <time_frame>9 months</time_frame>
    <description>T helper (CD4) (%)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lymphocyte subtypes 2</measure>
    <time_frame>9 months</time_frame>
    <description>T cytotoxic (CD8) (%)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lymphocyte subtypes 3</measure>
    <time_frame>9 months</time_frame>
    <description>Treg (CD25 and CD127) (%)</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">53</enrollment>
  <condition>Pancreatitis</condition>
  <condition>Lymphocytic Infiltrate</condition>
  <condition>Immune System Diseases</condition>
  <arm_group>
    <arm_group_label>Mild pancreatitis</arm_group_label>
    <description>Patients with mild acute biliary pancreatitis according to Atlanta classification</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate Pancreatitis</arm_group_label>
    <description>Patients with moderate acute biliary pancreatitis according to Atlanta classification</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Severe pancreatitis</arm_group_label>
    <description>Patients with severe acute biliary pancreatitis according to Atlanta classification</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Healthy volunteers</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Flow Cytometric analysis</intervention_name>
    <description>Blood samples will be taken from the patients with biliary pancreatitis and healthy volunteers to perform flow-cytometric analysis and to determine lymphocyte subgroups</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Mild pancreatitis</arm_group_label>
    <arm_group_label>Moderate Pancreatitis</arm_group_label>
    <arm_group_label>Severe pancreatitis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute pancreatitis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-80 years old&#xD;
&#xD;
          -  Diagnosis of acute biliary pancreatitis&#xD;
&#xD;
          -  Sign the voluntary consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Being under 18 or older than 80&#xD;
&#xD;
          -  Not signing the voluntary consent form&#xD;
&#xD;
          -  Pancreatitis resulting from an interventional procedure (ERCP, surgery, etc.)&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Being a history of immunodeficiency&#xD;
&#xD;
          -  Cancer history&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oguzhagan Batikan, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>İstanbul Training and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>İstanbul Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34098</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gaziosmanpaşa Taksim Eğitim ve Araştırma Hastanesi</name>
      <address>
        <city>Istanbul</city>
        <zip>34900</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Wang W, Xiang HP, Wang HP, Zhu LX, Geng XP. CD4 + CD25 + CD127 high cells as a negative predictor of multiple organ failure in acute pancreatitis. World J Emerg Surg. 2017 Feb 2;12:7. doi: 10.1186/s13017-017-0116-7. eCollection 2017.</citation>
    <PMID>28174597</PMID>
  </reference>
  <reference>
    <citation>Yang Z, Zhang Y, Dong L, Yang C, Gou S, Yin T, Wu H, Wang C. The Reduction of Peripheral Blood CD4+ T Cell Indicates Persistent Organ Failure in Acute Pancreatitis. PLoS One. 2015 May 4;10(5):e0125529. doi: 10.1371/journal.pone.0125529. eCollection 2015.</citation>
    <PMID>25938229</PMID>
  </reference>
  <reference>
    <citation>Li J, Yang WJ, Huang LM, Tang CW. Immunomodulatory therapies for acute pancreatitis. World J Gastroenterol. 2014 Dec 7;20(45):16935-47. doi: 10.3748/wjg.v20.i45.16935. Review.</citation>
    <PMID>25493006</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>August 4, 2020</study_first_submitted>
  <study_first_submitted_qc>August 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2020</study_first_posted>
  <last_update_submitted>April 30, 2021</last_update_submitted>
  <last_update_submitted_qc>April 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Oguzkagan Batikan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>pancreatitis</keyword>
  <keyword>lymphocyte</keyword>
  <keyword>Flow-cytometry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Immune System Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

